<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02003586</url>
  </required_header>
  <id_info>
    <org_study_id>FDS-NAA-1462</org_study_id>
    <nct_id>NCT02003586</nct_id>
  </id_info>
  <brief_title>Effect of a Plant-based Ingredient on Generalized Hormonal Responses</brief_title>
  <official_title>Effect of a Plant-based Ingredient on Generalized Hormonal Responses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Unilever R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Unilever R&amp;D</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to determine the extent to which foods containing a plant-based
      ingredient affect blood glucose and hormonal response in healthy subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>120 minutes</time_frame>
    <description>Amylin (total) will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>120 minutes</time_frame>
    <description>Ghrelin (active) will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>120 minutes</time_frame>
    <description>Glucose-dependent insulinotropic peptide (gastric inhibitory polypeptide, GIP) (total) will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>120 minutes</time_frame>
    <description>Glucagon-like peptide-1 (GLP-1) (active) will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>120 minutes</time_frame>
    <description>Leptin will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>120 minutes</time_frame>
    <description>Pancreatic polypeptide (PP) will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>120 minutes</time_frame>
    <description>Peptide YY (PYY) (total) will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>120 minutes</time_frame>
    <description>Insulin will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>120 minutes</time_frame>
    <description>C-peptide will be assessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>120 minutes</time_frame>
    <description>Glucagon will be assessed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>180 and 240 minutes</time_frame>
    <description>Amylin (total) will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>180 and 240 minutes</time_frame>
    <description>Ghrelin (active) will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>180 and 240 minutes</time_frame>
    <description>Glucose-dependent insulinotropic peptide (gastric inhibitory polypeptide, GIP) (total) will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>180 and 240 minutes</time_frame>
    <description>Pancreatic polypeptide (PP) will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>180 and 240 minutes</time_frame>
    <description>Peptide YY (PYY) (total) will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>180 and 240 minutes</time_frame>
    <description>Leptin will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>180 and 240 minutes</time_frame>
    <description>Glucagon will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>180 and 240 minutes</time_frame>
    <description>Insulin will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>180 and 240 minutes</time_frame>
    <description>C-peptide will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AUC of post-prandial hormones</measure>
    <time_frame>180 and 240 minutes</time_frame>
    <description>Glucagon-like peptide-1 (GLP-1) (active) will be assessed.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Blood glucose response (+iAUC)</measure>
    <time_frame>120 and 180 minutes</time_frame>
    <description>Effect on blood glucose response.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Plant-based ingredient to a starchy meal</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Plant-based ingredient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Starchy meal alone</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No plant-based ingredient</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>plant-based ingredient</intervention_name>
    <arm_group_label>Plant-based ingredient to a starchy meal</arm_group_label>
    <arm_group_label>Starchy meal alone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>No plant-based ingredient</intervention_name>
    <arm_group_label>Plant-based ingredient to a starchy meal</arm_group_label>
    <arm_group_label>Starchy meal alone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy males, Age at start of the study &gt;20 and &lt;50 years;

          -  Body mass index (BMI) ≥ 20,0 and ≤ 25,0 kg/m2;

          -  Apparently healthy: no medical conditions which might affect the study measurements,
             absorption, metabolism and distribution (including diabetes type 1 and type 2,
             gastrointestinal dysfunction, gastrointestinal surgery and inflammatory diseases);

          -  Fasting blood glucose value of subjects is ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62-110
             mg/dl) at screening;

          -  Agreeing to be informed about medically relevant personal test-results by a physician;

          -  Informed consent signed;

          -  Willing to comply to study protocol during study;

          -  Covered by Health Insurance System and/or in compliance with the recommendations of
             National Law in force relating to biomedical research.

          -  Accessible veins on arms as determined by examination at screening.

        Exclusion Criteria:

          -  Any history of diabetes, hyper- (or hypo-) glycemia or other disorder of glucose
             metabolism;

          -  Blood donation in the past 2 months;

          -  Reported participation in another nutritional or biomedical trial 3 months before the
             pre-study examination or during the study;

          -  Reported participation in night shift work two weeks prior to pre-study investigation
             or during the study. Night work is defined as working between midnight and 6.00 AM;

          -  Reported intense sporting activities &gt; 10h/w;

          -  Consumption of &gt; 21 alcoholic drinks in a typical week;

          -  Not being used to eat breakfast;

          -  Reported use of any nicotine containing products in the six months preceding the study
             and during the study itself;

          -  Use of medication which interferes with study measurements;

          -  Reported dietary habits: medically prescribed diet, slimming diet;

          -  Not used to eat 3 meals a day;

          -  Vegetarian;

          -  Reported weight loss/gain (&gt;10%) in the last six month before the study;

          -  Being an employee of Unilever and CRO;

          -  Allergy or intolerance to food products and aversion to food products provided during
             the study;

          -  Subject who cannot be contacted in case of emergency;

          -  Subject who, in the judgment of the investigator, is likely to be non-compliant or
             uncooperative during the study, or unable to cooperate because of a language problem,
             poor mental development;

          -  Subject under guardianship;

          -  Subject who would receive more than 4500 euro's as indemnities for his participation
             in biomedical research within the 12 last months, including the indemnities for the
             present study.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yves DONAZZOLO, M.D., M.Sc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>EUROFINS OPTIMED, GIERES - France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Eurofins Optimed Clinical research</name>
      <address>
        <city>Gieres</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 22, 2013</study_first_submitted>
  <study_first_submitted_qc>December 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2013</study_first_posted>
  <last_update_submitted>April 8, 2014</last_update_submitted>
  <last_update_submitted_qc>April 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>subjects</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

